Consonance Capital Management’s Travere Therapeutics TVTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q2 | – | Sell |
-2,314,421
| Closed | -$33.8M | – | 36 |
|
2020
Q1 | $33.8M | Hold |
2,314,421
| – | – | 2.51% | 18 |
|
2019
Q4 | $32.9M | Hold |
2,314,421
| – | – | 2.01% | 20 |
|
2019
Q3 | $26.8M | Sell |
2,314,421
-1,498,095
| -39% | -$17.4M | 2.65% | 17 |
|
2019
Q2 | $76.6M | Sell |
3,812,516
-219,607
| -5% | -$4.41M | 5.42% | 5 |
|
2019
Q1 | $91.2M | Hold |
4,032,123
| – | – | 5.76% | 6 |
|
2018
Q4 | $91.2M | Buy |
4,032,123
+117,941
| +3% | +$2.67M | 6.71% | 6 |
|
2018
Q3 | $112M | Buy |
3,914,182
+70,811
| +2% | +$2.03M | 6.05% | 2 |
|
2018
Q2 | $105M | Buy |
3,843,371
+150,000
| +4% | +$4.09M | 6.76% | 4 |
|
2018
Q1 | $82.6M | Buy |
3,693,371
+48,933
| +1% | +$1.09M | 7.55% | 4 |
|
2017
Q4 | $76.8M | Buy |
3,644,438
+138,834
| +4% | +$2.93M | 6.94% | 6 |
|
2017
Q3 | $87.3M | Buy |
3,505,604
+1,067,064
| +44% | +$26.6M | 9.65% | 2 |
|
2017
Q2 | $47.3M | Buy |
2,438,540
+306,400
| +14% | +$5.94M | 5.57% | 11 |
|
2017
Q1 | $39.4M | Sell |
2,132,140
-640,016
| -23% | -$11.8M | 4.13% | 13 |
|
2016
Q4 | $52.5M | Sell |
2,772,156
-312,791
| -10% | -$5.92M | 5.76% | 6 |
|
2016
Q3 | $69M | Buy |
3,084,947
+385,000
| +14% | +$8.62M | 6.65% | 6 |
|
2016
Q2 | $48.1M | Sell |
2,699,947
-30,000
| -1% | -$534K | 6.81% | 6 |
|
2016
Q1 | $37.3M | Sell |
2,729,947
-730,376
| -21% | -$9.98M | 5.64% | 10 |
|
2015
Q4 | $66.8M | Buy |
3,460,323
+10,000
| +0.3% | +$193K | 8.95% | 6 |
|
2015
Q3 | $69.9M | Buy |
3,450,323
+50,000
| +1% | +$1.01M | 9.84% | 4 |
|
2015
Q2 | $113M | Buy |
3,400,323
+292,613
| +9% | +$9.7M | 11.33% | 1 |
|
2015
Q1 | $74.5M | Buy |
3,107,710
+556,175
| +22% | +$13.3M | 6.78% | 6 |
|
2014
Q4 | $31.2M | Buy |
2,551,535
+1,012,076
| +66% | +$12.4M | 4.02% | 11 |
|
2014
Q3 | $13.9M | Buy |
+1,539,459
| New | +$13.9M | 1.91% | 18 |
|